Macro Biologics, Inc. awarded additional $5M award from CARB-X for Phase 1 clinical trial of Amicidin-β topical solution
Macro Biologics, Inc. awarded additional $5M award from CARB-X for Phase 1 clinical trial of Amicidin-β topical solution
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.
Toggle navigation